219 related articles for article (PubMed ID: 26198547)
21. Risk of calcium oxalate nephrolithiasis after calcium or combined calcium and calcitriol supplementation in postmenopausal women.
Domrongkitchaiporn S; Ongphiphadhanakul B; Stitchantrakul W; Piaseu N; Chansirikam S; Puavilai G; Rajatanavin R
Osteoporos Int; 2000; 11(6):486-92. PubMed ID: 10982163
[TBL] [Abstract][Full Text] [Related]
22. Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.
Laube N; Hergarten S; Hoppe B; Schmidt M; Hesse A
J Urol; 2004 Jul; 172(1):355-9. PubMed ID: 15201810
[TBL] [Abstract][Full Text] [Related]
23. Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules.
Wesson JA; Worcester EM; Wiessner JH; Mandel NS; Kleinman JG
Kidney Int; 1998 Apr; 53(4):952-7. PubMed ID: 9551403
[TBL] [Abstract][Full Text] [Related]
24. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones.
Khan SR; Glenton PA; Backov R; Talham DR
Kidney Int; 2002 Dec; 62(6):2062-72. PubMed ID: 12427130
[TBL] [Abstract][Full Text] [Related]
25. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L
Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273
[TBL] [Abstract][Full Text] [Related]
26. 24-Hour Urine Calcium Oxalate Supersaturation Risk Correlates with Computerized Tomography Volumetric Calcium Oxalate Stone Growth.
Yuzhakov S; Steadman SD; Otto BJ; Bird VG; Canales BK
J Urol; 2021 Dec; 206(6):1438-1444. PubMed ID: 34288713
[TBL] [Abstract][Full Text] [Related]
27. Assessment of crystallization risk formulas in pediatric calcium stone-formers.
Sikora P; Zajaczkowska M; Hoppe B
Pediatr Nephrol; 2009 Oct; 24(10):1997-2003. PubMed ID: 19333626
[TBL] [Abstract][Full Text] [Related]
28. Calcium oxalate urolithiasis in children: urinary promoters/inhibitors and role of their ratios.
Turudic D; Batinic D; Golubic AT; Lovric M; Milosevic D
Eur J Pediatr; 2016 Dec; 175(12):1959-1965. PubMed ID: 27730307
[TBL] [Abstract][Full Text] [Related]
29. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats.
Bushinsky DA; Bashir MA; Riordon DR; Nakagawa Y; Coe FL; Grynpas MD
Kidney Int; 1999 Feb; 55(2):602-12. PubMed ID: 9987084
[TBL] [Abstract][Full Text] [Related]
30. The relationship of 3' vitamin D receptor haplotypes to urinary supersaturation of calcium oxalate salts and to age at onset and familial prevalence of nephrolithiasis.
Mossetti G; Rendina D; Viceconti R; Manno G; Guadagno V; Strazzullo P; Nunziata V
Nephrol Dial Transplant; 2004 Sep; 19(9):2259-65. PubMed ID: 15213319
[TBL] [Abstract][Full Text] [Related]
31. Reduced crystallization inhibition by urine from women with nephrolithiasis.
Asplin JR; Parks JH; Nakagawa Y; Coe FL
Kidney Int; 2002 May; 61(5):1821-9. PubMed ID: 11967033
[TBL] [Abstract][Full Text] [Related]
32. [Inhibitory effect of CG-120 on the formation, growth and aggregation of calcium oxalate crystals in vitro].
Suzuki K; Tsugawa R
Hinyokika Kiyo; 1988 Jun; 34(6):1073-6. PubMed ID: 3223452
[TBL] [Abstract][Full Text] [Related]
33. Dependence of upper limit of metastability on supersaturation in nephrolithiasis.
Asplin JR; Parks JH; Coe FL
Kidney Int; 1997 Dec; 52(6):1602-8. PubMed ID: 9407506
[TBL] [Abstract][Full Text] [Related]
34. Cystine: a promoter of the growth and aggregation of calcium oxalate crystals in normal undiluted human urine.
Martins MC; Meyers AA; Whalley NA; Rodgers AL
J Urol; 2002 Jan; 167(1):317-21. PubMed ID: 11743349
[TBL] [Abstract][Full Text] [Related]
35. Glycine suppresses kidney calcium oxalate crystal depositions via regulating urinary excretions of oxalate and citrate.
Lan Y; Zhu W; Duan X; Deng T; Li S; Liu Y; Yang Z; Wen Y; Luo L; Zhao S; Wang J; Zhao Z; Wu W; Zeng G
J Cell Physiol; 2021 Oct; 236(10):6824-6835. PubMed ID: 33772775
[TBL] [Abstract][Full Text] [Related]
36. Measurement of the risk of calcium oxalate crystallization in urine.
Tiselius HG
Urol Res; 1985; 13(6):297-300. PubMed ID: 4095829
[TBL] [Abstract][Full Text] [Related]
37. Expression of proteins that inhibit calcium oxalate crystallization in vitro in the urine of normal and stone-forming individuals.
Hedgepeth RC; Yang L; Resnick MI; Marengo SR
Am J Kidney Dis; 2001 Jan; 37(1):104-112. PubMed ID: 11136174
[TBL] [Abstract][Full Text] [Related]
38. Effect of prothrombin and its activation fragments on calcium oxalate crystal growth and aggregation in undiluted human urine in vitro: relationship between protein structure and inhibitory activity.
Grover PK; Ryall RL
Clin Sci (Lond); 2002 Apr; 102(4):425-34. PubMed ID: 11914105
[TBL] [Abstract][Full Text] [Related]
39. Kinetics of calcium oxalate crystal formation in urine.
Laube N; Klein F; Bernsmann F
Urolithiasis; 2017 Apr; 45(2):151-157. PubMed ID: 27328814
[TBL] [Abstract][Full Text] [Related]
40. Effects of urinary macromolecules on the crystallization of calcium oxalate.
Tiselius HG; Fornander AM; Nilsson MA
Urol Res; 1990; 18(6):381-5. PubMed ID: 2100412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
